1. Home
  2. VBTX vs SUPN Comparison

VBTX vs SUPN Comparison

Compare VBTX & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VBTX
  • SUPN
  • Stock Information
  • Founded
  • VBTX 2009
  • SUPN 2005
  • Country
  • VBTX United States
  • SUPN United States
  • Employees
  • VBTX N/A
  • SUPN N/A
  • Industry
  • VBTX Major Banks
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VBTX Finance
  • SUPN Health Care
  • Exchange
  • VBTX Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • VBTX 1.6B
  • SUPN 1.9B
  • IPO Year
  • VBTX 2014
  • SUPN 2012
  • Fundamental
  • Price
  • VBTX $29.37
  • SUPN $35.82
  • Analyst Decision
  • VBTX Strong Buy
  • SUPN Hold
  • Analyst Count
  • VBTX 5
  • SUPN 1
  • Target Price
  • VBTX $29.40
  • SUPN $36.00
  • AVG Volume (30 Days)
  • VBTX 392.2K
  • SUPN 425.0K
  • Earning Date
  • VBTX 10-22-2024
  • SUPN 11-04-2024
  • Dividend Yield
  • VBTX 2.71%
  • SUPN N/A
  • EPS Growth
  • VBTX N/A
  • SUPN 130.79
  • EPS
  • VBTX 1.56
  • SUPN 1.07
  • Revenue
  • VBTX $370,982,000.00
  • SUPN $651,972,000.00
  • Revenue This Year
  • VBTX N/A
  • SUPN $7.82
  • Revenue Next Year
  • VBTX $3.92
  • SUPN N/A
  • P/E Ratio
  • VBTX $18.55
  • SUPN $33.77
  • Revenue Growth
  • VBTX N/A
  • SUPN 6.79
  • 52 Week Low
  • VBTX $18.08
  • SUPN $25.53
  • 52 Week High
  • VBTX $30.87
  • SUPN $39.37
  • Technical
  • Relative Strength Index (RSI)
  • VBTX 58.96
  • SUPN 54.35
  • Support Level
  • VBTX $28.56
  • SUPN $34.86
  • Resistance Level
  • VBTX $30.46
  • SUPN $39.37
  • Average True Range (ATR)
  • VBTX 0.81
  • SUPN 1.71
  • MACD
  • VBTX -0.09
  • SUPN -0.16
  • Stochastic Oscillator
  • VBTX 67.25
  • SUPN 40.24

About VBTX Veritex Holdings Inc.

Veritex Holdings Inc is engaged in the provision of commercial banking products and services to small to medium-sized businesses and professionals. The bank provides a range of banking services to individual and corporate customers, which include commercial and retail lending, and the acceptance of checking and savings deposits. It offers a suite of online banking solutions, including access to account balances, online transfers, online bill payment and electronic delivery of customer statements, as well as automated teller machines, and banking by telephone, mail and personal appointment. The company's primary sources of revenue are derived from interest and dividends earned on loans, debt and equity securities and other financial instruments.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: